Please be patient while the object screen loads.
Please use this identifier to cite or link to this item : http://hdl.handle.net/2078.1/11170
Apoptosis plays a central role not only in the physiological processes of kidney growth and remodeling, but also in various human renal diseases and drug-induced nephrotoxicity. We present in a synthetic fashion the main molecular and cellular pathways leading to drug-induced apoptosis in kidney and the mechanisms regulating it. We illustrate them using three main nephrotoxic drugs (cisplatin, gentamicin, and cyclosporine A). We discuss the main regulators and effectors that have emerged as key targets for the design of therapeutic strategies. Novel approaches using gene therapy, antisense strategies, recombinant proteins, or compounds obtained from both classical organic and combinatorial chemistry are examined. Finally, key issues that need to be addressed for the success of apoptosis-based therapies are underlined.
|Publication Date :||2008|
|Document type :||Article de périodique (Journal article) - (Article de recherche) - (Journal Article - Research Support, Non-U.S. Gov’t - Review)|
|Source :||“Apoptosis : an international journal on programmed cell death” - Vol. 13, no. 1, p. 11-32 (2008)|
|Publisher :||Springer New York LLC ((United States) New York)|
|Publication status :||Publié|
|MESH :||Mitochondria - drug effects - metabolism ; Metabolic Networks and Pathways ; Kidney Failure - metabolism ; Kidney - cytology - drug effects ; Humans ; Gentamicins - metabolism - toxicity ; Cyclosporine - metabolism - toxicity ; Cisplatin - metabolism - toxicity ; Caspases - metabolism ; Apoptosis Regulatory Proteins - metabolism ; Apoptosis - drug effects ; Animals|
|PDF-01||Adobe Acrobat PDF||558 KB||Request copy|
|PDF_01||pdf document||558 KB||Request copy|